NRF2 Deficiency Promotes Ferroptosis of Astrocytes Mediated by Oxidative Stress in Alzheimer's Disease.
Zhi TangZhuyi ChenMin GuoYaqian PengYan XiaoZhizhong GuanRuiqing NiXiaolan QiPublished in: Molecular neurobiology (2024)
Oxidative stress is involved in the pathogenesis of Alzheimer's disease (AD), which is linked to reactive oxygen species (ROS), lipid peroxidation, and neurotoxicity. Emerging evidence suggests a role of nuclear factor (erythroid-derived 2)-like 2 (Nrf2), a major source of antioxidant response elements in AD. The molecular mechanism of oxidative stress and ferroptosis in astrocytes in AD is not yet fully understood. Here, we aimed to investigate the mechanism by which Nrf2 regulates the ferroptosis of astrocytes in AD. We found decreased expression of Nrf2 and upregulated expression of the ROS marker NADPH oxidase 4 (NOX4) in the frontal cortex from patients with AD and in the cortex of 3×Tg mice compared to wildtype mice. We demonstrated that Nrf2 deficiency led to ferroptosis-dependent oxidative stress-induced ROS with downregulated heme oxygenase-1 and glutathione peroxidase 4 and upregulated cystine glutamate expression. Moreover, Nrf2 deficiency increased lipid peroxidation, DNA oxidation, and mitochondrial fragmentation in mouse astrocytes (mAS, M1800-57). In conclusion, these results suggest that Nrf2 deficiency promotes ferroptosis of astrocytes involving oxidative stress in AD.
Keyphrases
- oxidative stress
- cell death
- dna damage
- reactive oxygen species
- diabetic rats
- ischemia reperfusion injury
- poor prognosis
- induced apoptosis
- nuclear factor
- toll like receptor
- functional connectivity
- type diabetes
- replacement therapy
- hydrogen peroxide
- long non coding rna
- metabolic syndrome
- fatty acid
- cognitive decline
- cell free
- mild cognitive impairment
- heat shock protein
- anti inflammatory
- nucleic acid